Emergency Use Authorization

Emergency Use Authorization (EUA) is an authorization issued for unregistered drugs and vaccines in a public health emergency. The FDA Director General, by virtue of the Executive Order No. 121 of the President of the Philippines, authorizes the issuance of the EUA.

List of COVID-19 Vaccines Authorized by the FDA

• Pfizer-BioNTech/Comirnaty COVID-19 mRNA Vaccine (nucleoside modified)
• ChAdOx1-S[recombinant] VAXZEVRIA (COVID-19 Vaccine AstraZeneca)
• SARS-CoV-2 Vaccine (Vero Cell), Inactivated [Coronavac]
• Sputnik V Gam-COVID-Vac/Sputnik Light COVID-19 Vaccine
• Janssen COVID-19 Vaccine (Ad26.COV2-S (recombinant))
• Whole Virion, Inactivated Corona Virus Vaccine [Covaxin]
• COVID-19 mRNA Vaccine (nucleoside modified) [COVID-19 Vaccine Moderna]
• COVID-19 Vaccine (Vero Cell), Inactivated [COVID-19 Vaccine Sinopharm]
• SARS-CoV-2 rS Protein Nanoparticle Vaccine [Covovax]

List of COVID-19 Drugs Authorized by the FDA

Reports of suspected adverse reaction to COVID-19 vaccines

The FDA publishes an overview of reports of suspected adverse reactions to COVID-19 vaccines that is currently in use in the vaccination program of the Philippines.

The reports of suspected adverse drug reactions issued on a weekly basis have provided timely and relevant information to the healthcare professionals and the public on the safety of COVID-19 vaccines used in the vaccination program of the government as implemented by the National COVID-19 Vaccination Operations Center. In line with the high vaccination coverage and operational strategy, updates will be on a monthly basis. Monitoring the safety of COVID-19 vaccines shall remain on a regular interval.

Status as of 31 July 2023

Total number of doses administered: 181,645,251
Number of fully vaccinated individuals: 78,443,972
Number of individuals with booster shots: 23,811,248
Number of reports of suspected adverse reaction: 113,002 (0.06% of doses administered)

• as of 31 July 2023

To report a suspected side effect, click here.